论文信息 - Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy. - 字舞流文

Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy.

M. Sadelain | R. Brentjens | B. Sénéchal | B. Santomasso | I. Rivière | Xiuyan Wang | Jae H. Park | Daniel H. Li | Y. Bernal | Yongzeng Wang | C. Diamonte | E. Halton | E. Mead